IP Library › Granted Patent US 8,969,011
Granted Patent B2
US 8,969,011 · App. 13/257,382 · Granted Mar 3, 2015

Microorganism concentration process and device

Inventors: Manjiri T. Kshirsagar (Woodbury, MN); Andrew W. Rabins (St. Paul, MN)
Assignee: 3M Innovative Properties Company
B01D61/147B01D63/00C12Q1/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,969,011
App. No.
13/257,382
Granted
Mar 3, 2015
Kind
B2
Abstract

A process for capturing or concentrating microorganisms for detection or assay comprises (a) providing a concentration device comprising a sintered porous polymer matrix comprising at least one concentration agent that comprises an amorphous metal silicate and that has a surface composition having a metal atom to silicon atom ratio of less than or equal to 0.5, as determined by X-ray photoelectron spectroscopy (XPS); (b) providing a sample comprising at least one microorganism strain; and (c) contacting the concentration device with the sample such that at least a portion of the at least one microorganism strain is bound to or captured by the concentration device.

Claims (18)

1. A process comprising (a) providing a concentration device comprising a sintered porous polymer matrix comprising at least one concentration agent that comprises an amorphous metal silicate and that has a surface composition having a metal atom to silicon atom ratio of less than or equal to 0.5, as determined by X-ray photoelectron spectroscopy (XPS); (b) providing a sample comprising at least one microorganism strain; and (c) contacting said concentration device with said sample such that at least a portion of said at least one microorganism strain is bound to or captured by said concentration device.

2. The process of claim 1 , wherein said process further comprises detecting the presence of at least one bound microorganism strain.

3. The process of claim 2 , wherein said detecting is carried out by a method selected from culture-based methods, microscopy and other imaging methods, genetic detection methods, immunologic detection methods, luminescence-based detection methods, and combinations thereof.

4. The process of claim 1 , wherein said process further comprises separating said concentration device from said sample and/or culturally enriching at least one bound microorganism strain and/or separating at least a portion of at least one bound microorganism strain from said concentration device.

5. The process of claim 1 , wherein said sintered porous polymer matrix comprises at least one thermoplastic polymer.

6. The process of claim 5 , wherein said thermoplastic polymer is selected from olefin homopolymers, olefin copolymers, copolymers of olefins and other vinyl monomers, and combinations thereof.

7. The process of claim 6 , wherein said thermoplastic polymer is selected from olefin homopolymers and combinations thereof.

8. The process of claim 7 , wherein said olefin homopolymer is polyethylene.

9. The process of claim 1 , wherein said concentration device comprises a tortuous path matrix.

10. The process of claim 1 , wherein said surface composition has a metal atom to silicon atom ratio of less than or equal to 0.4.

11. The process of claim 1 , wherein said surface composition is at least 10 average atomic percent carbon.

12. The process of claim 1 , wherein said concentration agent has a negative zeta potential at a pH of 7.

13. The process of claim 1 , wherein said metal is selected from magnesium, calcium, zinc, aluminum, iron, titanium, and combinations thereof.

14. The process of claim 13 , wherein said metal is magnesium.

15. The process of claim 1 , wherein said concentration agent comprises an amorphous metal silicate in at least partially fused particulate form.

16. The process of claim 15 , wherein said concentration agent is amorphous, spheroidized magnesium silicate.

17. The process of claim 1 , wherein said microorganism strain is selected from strains of bacteria, fungi, yeasts, protozoans, viruses, bacterial endospores, and combinations thereof.

18. The process of claim 1 , wherein said contacting is carried out by passing said sample through said concentration device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2011
From: KSHIRSAGAR, MANJIRI T.; RABINS, ANDREW W.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 026926/0884 →
Continuity (2)
Provisional Application 61166266 · Apr 3, 2009
Related Publication 20120034621A1 · Feb 9, 2012